Profil
Sandford Sommer is currently the President & Chief Operating Officer at Ligand UK Ltd.
He previously worked as the Director at UK Colombia Trade and as the President-Colombia operations at AstraZeneca PLC.
Aktive Positionen von Sandford Sommer
| Unternehmen | Position | Beginn |
|---|---|---|
| VERNALIS | President | 01.05.2016 |
Ehemalige bekannte Positionen von Sandford Sommer
| Unternehmen | Position | Ende |
|---|---|---|
| UK Colombia Trade | Director/Board Member | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
| UK Colombia Trade |
